Lasa Supergenerics Ltd

LASA
NSE· Healthcare
₹7.11
-0.19 (-2.60%)
Updated 11:27 am IST
52W Low · ₹5.6752W High · ₹14.08
Near 52W Low
Market Cap
₹39.63L Cr
Volume
32.8K
Prev Close
₹7.30
ISIN
INE670X01014

Orion Score

Fundamentals-based quality & risk · not a recommendation

15/100
Avoid

Lasa Supergenerics Ltd scores 15/100 (Avoid) on the Orion Score — poor business quality (9), poor growth (8) and weak balance-sheet safety (35). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality
9
Growth
8
Safety
35
Value
—

Full Orion analysis

Risk checks

  • Very weak fundamentals (Piotroski F 1/9)
  • Micro-cap (~Rs 40 cr) — limited reliability/liquidity
  • Thinly traded (~Rs 2.6 L/day) — hard to act on

Forensic accounting

Piotroski F 1/9Altman Z Grey(2.31)Beneish M Clean(-4.92)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

41/100

Neutral

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION
Low Debt
D/E 0.13x — lean balance sheet
QUALITY
Low Quality
ROCE -7.2% — poor capital efficiency
MOMENTUM
Bearish
RSI 41.0 — weak momentum

Price Chart

SMA 20
SMA 50
SMA 200

Key Fundamentals

Q3 FY2026

P/E Ratio
2.05
ROCE
-7.15%
ROE (1Y)
—
D/E Ratio
0.13x
OPM
-105.35%
TTM EPS
₹-8.83
Dividend Yield
—
Qtrly Sales
₹2.20 Cr
Qtrly Profit
₹-2.55 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit
QuarterRevenueNet ProfitOPMEPS
Q3 2026₹2.2₹-2.55-105.5%₹-0.51
Q2 2026₹3.06₹-6.25-182.0%₹1.25
Q1 2026₹20.01₹-21.12-10.3%₹-4.22
Q4 2025₹39.14₹-14.29-2.6%—
Q3 2025₹33.08₹5.49-7.7%₹1.10

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit
YearRevenueNet ProfitEBITDAOPM
FY 2025₹142.45₹-14.76₹-4.39-4.2%
FY 2024₹104.33₹-21.73₹-6.51-8.2%
FY 2023₹129.57₹-38.62₹-24.69-14.0%
FY 2022₹137.13₹-5.33₹8.41.7%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

CompanyMkt CapP/EROCEROED/EOPM
LASA ★₹40 Cr2.05-7.15%—0.13x-105.35%
SUNPHARMA₹4,27,609 Cr37.3215.73%14.72%0.06x18.90%
MAXHEALTH₹95,110 Cr66.2111.94%14.33%0.32x22.56%
AUROPHARMA₹90,029 Cr25.9412.55%9.93%0.21x15.11%
ABBOTINDIA₹57,724 Cr36.6336.14%34.46%0.04x27.01%
AJANTPHARM₹41,836 Cr39.5527.99%25.39%0.06x51.40%

Balance Sheet

All values in ₹ Crores

MetricFY 2025FY 2024FY 2023FY 2022
Total Assets₹101.53₹150.87₹163.85₹209.17
Equity₹83.71₹96.68₹118.29₹157.88
Total Debt₹2.13₹22.08₹21.77₹20.17
Cash₹0.26₹0.6₹0.8₹11.07
Net Debt₹1.86₹21.48₹20.97₹9.11
Working Capital₹15.36₹-10.98₹-3.51₹21.55

Shareholding Pattern

Q1 FY2027

Promoter
54.65%
FII
0%
DII
0%
Public
45.35%

Quarter-over-Quarter Trend

QuarterPromoterFIIDIIPublic
Q1 FY202754.65% ↑0%0%45.35% ↓
Q3 FY202653.65%0%—46.34%
Q2 FY202653.65%0% ↓—46.35% ↑
Q1 FY202653.65%0.47% ↑—45.88% ↓
Q4 FY202553.65%0%—46.35%
Q3 FY202553.65%0% ↓—46.35% ↑
Q2 FY202553.65%0.01% ↑—46.32% ↓
Q1 FY202553.65%0%—46.34%

Corporate Actions

No recent corporate actions

Analyse LASA with Orion AI

Ask: "Is Lasa Supergenerics Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Lasa Supergenerics Ltd (LASA) Stock

Lasa Supergenerics Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE670X01014. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.